Interestingly, a defect in lysosomal trafficking caused by a PD-associated GBA mutation (L444P) was rescued in Gaucher patient-derived fibroblasts following treatment with the L-type Ca2+ channel blockers diltiazem or verapamil (Mu et al., 2008). This evidence concerns the gene GBA1 and Parkinson disease.